The GAA gene gives your cells instructions to make an enzyme that breaks down stored sugar called glycogen. When this enzyme does not work properly, glycogen builds up inside cells, especially in muscle, and this causes Pompe disease. Depending on the variant and how much enzyme activity remains, people may develop muscle weakness, breathing problems, and sometimes an enlarged heart, with symptoms beginning in infancy, childhood, or adulthood.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the active parts of cells. Other genes mainly guide when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this subject, you can find more in the LearnHub.
Overview
GAAGene function
What if the gene works
The GAA gene helps cells make acid alpha-glucosidase, an enzyme that breaks down stored glycogen into glucose inside lysosomes, the cell’s recycling spaces. This helps muscles and other tissues use stored sugar normally.
Risk
What if the gene does not work
Pathogenic variants in the GAA gene cause Pompe disease. More severe variants often lead to infancy-onset heart enlargement and muscle weakness, while milder variants may cause later-onset muscle weakness and breathing problems.
Treatment
What does that mean for your treatment
Pathogenic variants in the GAA gene can make enzyme replacement therapy a key treatment option, including alglucosidase alfa or avalglucosidase alfa. In infantile-onset disease, variants linked to little or no enzyme production may suggest CRIM-negative status, which can guide adding immune tolerance medicines alongside enzyme therapy.
Conditions associated with GAA
Gene function
What if the gene works
Your cells store some sugar as glycogen for later use. Inside tiny recycling compartments called lysosomes, the GAA gene helps turn part of that stored sugar back into smaller sugar units. This everyday step is especially important in cells that handle a steady energy demand, such as muscle and heart cells. Understanding how the GAA gene helps break down glycogen shows how cells manage stored fuel over time.
Inside lysosomes, the protein from the GAA gene cuts long glycogen chains into smaller sugar units. This is a routine step in how cells handle stored sugar during normal day to day activity.
Lysosomes act like recycling centers, and the GAA gene helps them process glycogen that reaches this compartment. This supports tidy cell housekeeping and helps stored material move through the system efficiently.
By releasing smaller sugar units from glycogen, the GAA gene supports normal handling of stored fuel within cells. This contributes to everyday cell maintenance, particularly in muscle and heart cells.
What is a variant?
Within a gene, the DNA sequence can differ slightly; this is called a genetic variant. These differences are common and help shape normal human diversity, including appearance, metabolism, and how the body responds to environmental influences. Most variants do not produce noticeable effects and are simply part of natural genetic variation. At times, though, a variant affects gene function more strongly and can contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GAA gene can reduce how much acid alpha-glucosidase is made, cause the protein to fold poorly, or stop enough of it from reaching lysosomes, the cell’s recycling centers. This spectrum of GAA gene variants in Pompe disease ranges from milder changes that leave some enzyme activity to more severe variants that leave little or none. That difference in remaining activity often helps explain why symptoms may begin earlier or later and why severity can vary.
How variants are linked to conditions
Pathogenic variants in both copies of the GAA gene cause Pompe disease, a rare inherited condition that can affect muscles, movement, breathing, and sometimes the heart. In clinical genetics, the GAA gene and Pompe disease link is well established, with forms ranging from infant-onset disease to later-onset symptoms in childhood or adulthood. Carrying one variant usually means a person is a carrier rather than affected.
A variant is not necessarily a diagnosis
Variants in genes are a normal part of human biology and are common across the general population. Most do not have a direct effect on health and simply represent natural human diversity. For many genes, carrying a variant connected with a condition points to a possible association rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GAA, risk is mainly set by the variants inherited at birth. Family history and having two disease-causing GAA variants, or being a carrier with a carrier partner, can change the chance of Pompe disease in a child; lifestyle factors are not known to meaningfully change this genetic risk.
Inheritance of GAA variants
Variants in the GAA gene that cause Pompe disease are inherited in an autosomal recessive pattern. This means a child usually inherits one changed copy of the GAA gene from each parent. When both parents are carriers, each pregnancy has a 25% chance of Pompe disease, a 50% chance that the child will be a carrier, and a 25% chance that the child will inherit two working copies. In practical terms, how GAA gene variants are inherited often becomes clear only after a family member is diagnosed or carrier testing is done.
What does my GAA result mean for my family?
For families, a GAA result usually means close relatives could also carry the same gene change, even if they feel completely well. Brothers, sisters, and children may want to learn whether they are carriers, especially if Pompe disease is already known in the family. If both parents carry a changed GAA gene, more than one child in the family can be affected.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for GAA gene variants usually uses a blood sample, saliva, or a cheek swab. A lab reads the DNA in the GAA gene to look for variants linked with Pompe disease, which can help confirm a diagnosis or show whether someone is a carrier.
When should I consider getting a genetic test?
Consider GAA genetic testing if you or your child has signs that suggest Pompe disease, such as muscle weakness, breathing problems, or an enlarged heart in infancy. Testing may also help if newborn screening or an enzyme test points to Pompe disease, or if it runs in your family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you depends on the condition and on the kind of variant involved. How the body functions over time is shaped by many influences, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as response to medications, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This is common and can influence how well a medicine works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medicines. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body processes it. Understanding this can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the GAA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so general questions about medicines or side effects are best discussed with your doctor. In people living with GAA-related Pompe disease, doctors may sometimes look at the GAA result before enzyme replacement treatment because some gene changes can affect treatment response by increasing the chance of an immune reaction.
History
The history of the GAA gene is closely tied to Pompe disease, a condition first described in 1932 by Dutch pathologist Joannes Cassianus Pompe after he examined an infant with severe heart enlargement and unusual glycogen buildup. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became known as glycogen storage disease type II. From these first observations, research expanded steadily as scientists worked out that the missing enzyme activity was the key problem. In the late 20th century, researchers identified the GAA gene and linked harmful variants in it to Pompe disease. That discovery helped confirm diagnoses at the DNA level and supported the development of modern screening and treatment approaches. Today, the GAA gene remains a central part of newborn screening and inherited disease research.